| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $4.3B | $4.5B | $3.7B | $3.3B | $1.9B |
| Cost of Revenue | — | — | $3.0B | $2.7B | $1.6B |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | $0.5B | $0.4B | $0.3B | $0.3B | $0.2B |
| Operating Income | — | — | — | — | — |
| Net Income | $0.2B | $0.3B | $0.3B | $0.3B | $0.1B |
| EPS (Basic) | $2.19 | $3.44 | $3.03 | $2.67 | $1.27 |
| EPS (Diluted) | $2.14 | $3.34 | $2.79 | $2.45 | $1.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $3.7B | $3.3B | $2.6B | $2.4B | $1.9B |
| Current Assets | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.3B | $0.5B | $0.4B | $0.2B |
| Total Liabilities | $2.1B | $1.9B | $1.5B | $1.6B | $1.3B |
| Current Liabilities | — | — | — | — | — |
| Stockholders' Equity | $1.4B | $1.2B | — | — | — |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.1B | $-0.3B | $0.4B | $-0.0B | $0.1B |
| Investing Cash Flow | $-0.2B | $-0.2B | $-0.0B | $-0.0B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.3B | $0.3B | $-0.2B | $0.1B | $0.6B |